However, hPL levels were not clearly linked to maternal glycaemic outcomes in PGDM/GDM, despite pre-clinical evidence for physiological roles in both insulin resistance and maternal beta-cell adaptation to pregnancy. The gene discussed is INS; the disease is gestational diabetes.